ArticleExperimental and therapeutic medicine2022
LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
Xiaowen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it